Global Allergy Immunotherapy Market Professional Survey Report 2019

Allergen immunotherapy, also known as desensitization or hypo-sensitization, is a medical treatment for some types of allergies. It is useful for environmental allergies, allergies to insect bites, and asthma. Its benefit for food allergies is unclear and thus not recommended. Immunotherapy involves exposing people to larger and larger amounts of allergen in an attempt to change the immune system's response.

The global Allergy Immunotherapy market was valued at xx million US$ in 2018 and will reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025.
This report focuses on Allergy Immunotherapy volume and value at global level, regional level and company level. From a global perspective, this report represents overall Allergy Immunotherapy market size by analyzing historical data and future prospect.
Regionally, this report categorizes the production, apparent consumption, export and import of Allergy Immunotherapy in North America, Europe, China, Japan, Southeast Asia and India.
For each manufacturer covered, this report analyzes their Allergy Immunotherapy manufacturing sites, capacity, production, ex-factory price, revenue and market share in global market.

The following manufacturers are covered:
ALK-Abello
Stallergenes Greer
Merck
Allergy Therapeutics
HAL
WOLW Pharma
Holister Stier
Leti

Segment by Regions
North America
Europe
China
Japan
Southeast Asia
India

Segment by Type
Subcutaneous Immunotherapy
Sublingual Immunotherapy

Segment by Application
Allergic Rhinitis
Allergic Asthma
Other